title: Nonsurgical treatment options in Peyronie's Disease: 2016 update.
abstract: Peyronie's disease (PD) is an inflammatory condition of penile tunica albuginea which commonly ends with penile curvature and difficulty in vaginal penetration. Unfortunately, the pathophysiology of PD has not been completely understood. In this paper, we will review what is known about the pathophysiology of PD and the nonsurgical medical treatment options that have been trialed as a result. In the last 5 years, commonly used oral medications left their places to intralesional therapies. Clostridium collagenase, which is the only Food and Drug Administration (FDA) approved treatment for PD, is now the most prescribed intralesional therapy in the last years. Clostridium collagenase is advised for patients whose penile curvature is > 30° and < 90°. Because of its side effects, patients should be counseled before intralesional Clostridium collagenase treatment. Until finding best treatment solution for PD, more investigations in regards to the basic science of PD need to be carried out in order to elucidate the exact mechanisms of the fibrosis.
authors.affiliation: Department of Urology, Hamad General Hospital, Doha, Qatar.
authors.forename: Raidh A
authors.initials: RA
authors.lastname: Talib
authors.affiliation: Department of Urology, Hamad General Hospital, Doha, Qatar.
authors.forename: Mohammed Abdulkareem
authors.initials: MA
authors.lastname: Ibrahim
authors.affiliation: Department of Urology, Hamad General Hospital, Doha, Qatar.
authors.forename: Önder
authors.initials: Ö
authors.lastname: Cangüven
keywords: Humans; male; penile induration; phosphodiesterase inhibitors